Follow this forum via email Follow this innovation hub [ via ] [?]
Innovation Hub

Rare diseases

"A rare disease, sometimes known as an orphan disease, is any disease that is not common...No single cutoff number has been agreed upon for which a disease is considered rare. A disease may be considered rare in one part of the world, or in a particular group of people, but still be common in another." - Wikipedia

Innovation represented on the iBridge Network targets diseases such as Cystic Fibrosis, Huntington disease, mesothelioma and genes such as BRCA1, BRCA2, and FAP.


The Latest Innovations
Fox Chase Cancer Center

16 DEC 11

Anti-murine Fibroblast Activation Protein (FAP) Polyclonal Antisera

Dr. Cheng and colleagues of Fox Chase Cancer Center have developed rabbit polyclonal antisera against recombinant murine FAP-ECD protein. These antisera can detect murine FAP in vitro and in vivo and have been used to detect FAP on paraffin embedded xenografts

University of Utah

31 MAR 11

Colon Tumor Specific Binding Peptides

Invention Summary: A short, cyclic peptide selectively binds and is internalized into colon cancer cells. It discriminates colon tissue from normal tissue and other cancer types. This invention targets HT29 cells. The APC gene is mutated in HT29 cells and 85% of colon cancers including all ...

University of Utah

31 MAR 11

The APC gene, for Detection and Diagnosis of Inherited and Sporadic Colorectal Cancer

Invention Summary: The adenomatous polyposis coli (APC) gene is a tumor suppressor gene which is altered in many colon cancers. Germline mutations of APC are the cause of familial adenomatous polyposis (FAP), an inherited syndrome which leads to the growth of hundreds of colon polyps and a ...

See All 3 innovations


Organizations
Followed By

Other Hubs

Autism

Pediatric

Cystic Fibrosis

Energy innovation

Parkinson’s disease

Blood-brain barrier

Neglected diseases

Engineering
Profile
Related Tags

Find more innovations


February 11, 2009

7,854 members 17,202 innovations 152 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...